Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urinary tract mucosal sensory nerve endings are specialized afferent fibers, primarily A-delta and C-fibers, located within the urothelium and suburothelial space of the bladder and urethra (Fowler et al., 2008). These nerve endings serve as the primary sensors for mechanical stretch and chemical stimuli, transmitting signals to the central nervous system to regulate the micturition reflex and signal pain (Birder & Andersson, 2013). They express a diverse array of molecular targets, including Transient Receptor Potential Vanilloid 1 (TRPV1), purinergic P2X3 receptors, and acid-sensing ion channels (ASICs) (Andersson, 2002). In conditions like overactive bladder (OAB) and interstitial cystitis, these sensory endings exhibit hypersensitivity or increased density, contributing to symptoms of urgency and chronic pelvic pain (Wyndaele et al., 2001). Therapeutic strategies often target these endings through intravesical administration of drugs like lidocaine to block sodium channels or capsaicin to desensitize TRPV1 receptors (Chancellor & de Groat, 1999). Additionally, botulinum toxin A is utilized to inhibit the release of sensory neuropeptides such as Substance P and Calcitonin Gene-Related Peptide (CGRP) from these terminals (Apostolidis et al., 2006).
Inhibition of voltage-gated sodium channels, desensitization of TRPV1 ion channels, and blockade of SNAP-25 mediated exocytosis of sensory neuropeptides (Fowler et al., 2008; Apostolidis et al., 2006).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urinary tract mucosal sensory nerve endings.